Tobramycin inhalation powder (Tobi Podhaler) for cystic fibrosis

Med Lett Drugs Ther. 2013 Jun 24;55(1419):51-2.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Inhalation
  • Adolescent
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / therapeutic use*
  • Chemistry, Pharmaceutical
  • Child, Preschool
  • Clinical Trials as Topic
  • Costs and Cost Analysis
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / drug therapy*
  • Drug Interactions
  • Female
  • Forced Expiratory Volume
  • Humans
  • Male
  • Nebulizers and Vaporizers
  • Powders
  • Pseudomonas Infections / complications
  • Pseudomonas Infections / drug therapy
  • Randomized Controlled Trials as Topic
  • Tobramycin / administration & dosage*
  • Tobramycin / adverse effects
  • Tobramycin / economics
  • Tobramycin / therapeutic use*
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Powders
  • Tobramycin